GLP1抑制剂用于治疗非糖尿病患者肥胖时的不良反应

{"title":"GLP1抑制剂用于治疗非糖尿病患者肥胖时的不良反应","authors":"María Estrella Barceló Colomer, Eladio Fernández Liz","doi":"10.1016/j.aprim.2025.103372","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":55435,"journal":{"name":"Atencion Primaria","volume":"57 12","pages":"Article 103372"},"PeriodicalIF":1.6000,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Reacciones adversas de los inhibidores de la GLP1, cuando se utilizan para tratar la obesidad en pacientes que no son diabéticos\",\"authors\":\"María Estrella Barceló Colomer, Eladio Fernández Liz\",\"doi\":\"10.1016/j.aprim.2025.103372\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":55435,\"journal\":{\"name\":\"Atencion Primaria\",\"volume\":\"57 12\",\"pages\":\"Article 103372\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-09-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Atencion Primaria\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0212656725001581\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Atencion Primaria","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0212656725001581","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}